Zynerba Pharmaceuticals (ZYNE)

[Fress]

Load up sit back and watch your investment grow potential 10x ROI in 24 months.


Something huge is cooking the ZYNE biosynthetic Lab We Break ALL time Highs of $36.50 in 2019.
Patented Biosynthetic Platform for CBD and THC

https://zynerba.com/our-focus/why-pharmaceutical-manufacturing/


68 Million in Cash up from 59 Million last quarter.


Float is extremely tight here. 18 Million Float 21 Total shares the volume over the past 2 months will launch ZYNE into the 20's only stock I feel comfortable holding in these market conditions. Creme de la Creme of Cannabis Biotech Multi Billion dollar company in the making.


No DEBT.


Also there is going to be a big short squeeze here now.


Analysts average target price is $24.00


there is 18% short interest.

shorts are going to get burned.


Many hammers and catalyst in Q2 Q3 Q4 2019

GWPH 5.6 Billion Market Cap
ZYNE 280 Million Market cap (superior CBD Pharmaceutical Grade No reliance on Plant like GWPH Pesticides etc

April 2019 ZYNE Company Overview:
http://ir.zynerba.com/static-files/e772c9c3-7f37-4f0b-8844-d5a5e601cbf3


$ZYNE